CGRP: A New Endogenous Cell Stemness Maintenance Molecule.

Xiaoting Lv, Qingquan Chen, Shuyu Zhang, Feng Gao, Qicai Liu

Oxidative medicine and cellular longevity 2022

filter terms:

Stem cells have the ability of self-replication and multidirectional differentiation, but the mechanism of how stem cells "maintain" this ability and how to "decide" to give up this state and differentiate into cells with specific functions is still unknown. The Nobel Prize in physiology and medicine in 2021 was awarded to "temperature and tactile receptor," which made the pain receptor TRPV1-calcitonin gene-related peptide (CGRP) pathway active again. The activation and blocking technology of CGRP has been applied to many clinical diseases. CGRP gene has complex structure and transcription process, with multiple methylation and other modification sites. It has been considered as a research hotspot and difficulty since its discovery. Drug manipulation of TRPV1 and inhibition of CGRP might improve metabolism and prolong longevity. However, whether the TRPV1-neuropeptide-CGRP pathway is directly or indirectly involved in stem cell self-replication and multidirectional differentiation is unclear. Recent studies have found that CGRP is closely related to the migration and differentiation of tumor stem cells, which may be realized by turning off or turning on the CGRP gene expression in stem cells and activating a variety of ways to regulate stem cell niches. In this study, we reviewed the advances in researches concentrated on the biological effects of CGRP as a new endogenous switching of cell stemness. Copyright © 2022 Xiaoting Lv et al.

Citation

Xiaoting Lv, Qingquan Chen, Shuyu Zhang, Feng Gao, Qicai Liu. CGRP: A New Endogenous Cell Stemness Maintenance Molecule. Oxidative medicine and cellular longevity. 2022;2022:4107433